Edition:
United States

Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

1.06USD
19 Oct 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.06
Open
--
Day's High
--
Day's Low
--
Volume
51
Avg. Vol
5,905,960
52-wk High
$1.78
52-wk Low
$0.73

Select another date:

Tue, Aug 8 2017

BRIEF-Novavax Q2 loss per share $0.16

* Q2 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Novavax reports Q2 loss per share $0.16

* Q2 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

BRIEF-Novavax announces positive topline data from phase 2 trial and provides path forward for RSV F vaccine programs

* Novavax announces positive topline data from phase 2 older adult trial and provides path forward for RSV F vaccine programs Source text for Eikon: Further company coverage:

BRIEF-Novavax reports Q1 loss per share $0.16

* Q1 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S

BRIEF-Novavax reports Q1 loss per share $0.16

* Q1 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Select another date: